Clinical Trials Directory

Trials / Completed

CompletedNCT01102933

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients - an Observational Study (REBUS)

Status
Completed
Phase
Study type
Observational
Enrollment
425 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The study is an open, single center, observational study at the Cardiology Dept at Uppsala University Hospital. The number of patients included will be 410. The objectives are to: Evaluate biomarkers and change of these related to myocardial infarction, during two years follow-up in an unselected patient population with a recent myocardial infarction. Evaluate if an early change of biomarkers can be related to death, new myocardial infarction, and ischemic stroke in the same population after two and five years follow-up.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2010-04-13
Last updated
2014-03-26

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01102933. Inclusion in this directory is not an endorsement.

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients (NCT01102933) · Clinical Trials Directory